Clinical Trials
5 trialsNCT02574728 2026-03-02
AflacST1502
Emory University
Phase 2 Active not recruiting
NCT01614795 2018-12-11
Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00743509 2015-09-28
OCR
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT01016015 2015-07-30
Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT02429973 2015-04-29
GEIS-29
Broto, Javier MartÃn, M.D.
Phase 2 Completed